“These successes are surprising, worth discussing, and even celebrating a bit,” STAT Lab Dish columnist Paul Knoepfler writes of the FDA and stem cells.
Opinion: STAT+: A surprising bright spot at the FDA on regulating unproven stem cells
“These successes are surprising, worth discussing, and even celebrating a bit,” STAT Lab Dish columnist Paul Knoepfler writes of the FDA and stem cells.